TRIM5alpha association with cytoplasmic bodies is not required for antiretroviral activity (Q50753410)
scientific article published on 22 September 2005
Language:
Current Data About TRIM5alpha association with cytoplasmic bodies is not required for antiretroviral activity
(P31) (Q13442814)
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(P50) (Q64524473)
(P1545) 6
(P1932) Joseph Sodroski
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018

(Q115249309)
(P1545) 5
(P1932) Matthew Stremlau
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(Q114413254)
(P1545) 2
(P1932) Felipe Diaz-Griffero
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(Q115249312)
(P1545) 1
(P1932) Byeongwoon Song
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(P304) 201-211
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(P407) (Q1860)

(P433) 2
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(P478) 343
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(P577) Thursday, September 22, 2005
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(P921) (Q50430310)

(P1104) 11
(P887)

(P1433) (Q7934867)
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(P1476) "TRIM5alpha association with cytoplasmic bodies is not required for antiretroviral activity" (language: en)
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(P2093) Do Hyun Park
(P1545) 3
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

Thomas Rogers
(P1545) 4
(P248)
(P698) 16183097
(P813) Sunday, March 18, 2018
(P854) http://europepmc.org/abstract/MED/16183097

(P2860) (Q34329994)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q35161554)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q34637179)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q24561939)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q44532890)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q71096662)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q50768103)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q28292275)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q24561930)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q24533430)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q37416225)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q24291183)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q55245697)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q45097220)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q29618741)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q45788277)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q33780572)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q33707501)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q34153599)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q29547689)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q24564127)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q24310515)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q24561922)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

(Q44946243)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.019
(P813) Thursday, January 7, 2021

other details
description scientific article published on 22 September 2005

External Links
(P356) 10.1016/J.VIROL.2005.08.019
(P698) 16183097
(P5875) 7581303